Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
The YB1 Way of Surviving Radiation, Pediatric Brain Tumor Resistance and Recurrence	Emory University / Abhinav Dey, PhD	Young Investigator Grants	2015	Georgia
Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells	Stanford University / Ramin Dubey, PhD	Young Investigator Grants	2015	California
Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors	University of Florida / Catherine Flores, PhD	Young Investigator Grants	2015	Florida
Single Cell Analysis of Leukemia Initiation	Stanford University / Michael Cleary, MD	Innovation Grants	2015	California
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma	Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP)	Innovation Grants	2015	Virginia
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy	University of North Carolina / Timothy Gershon, MD, PhD	Innovation Grants	2015	North Carolina
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma	Children's Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD	Innovation Grants	2015	California
Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb	University of Wisconsin - Madison / Paul Sondel, MD, PhD	Innovation Grants	2015	Wisconsin
Cure Osteosarcoma Lung Metastasis by Disrupting Tumor VCAM-1 Signaling with Macrophages	Case Western Reserve University / Alex Huang, MD, PhD	Innovation Grants	2015	Ohio
Functional Analysis and Therapeutic Targeting of STAG2 Mutations in Ewing sarcoma	Georgetown University / Todd Waldman, MD, PhD	Innovation Grants	2015	District of Columbia

Pages